Filing Flows › Angi (ANGI) › Q3 2026 › vs Q2 2026
Angi (ANGI) Q3 2026 vs Q2 2026 (quarter over quarter)
Angi's revenue fell $6.0M (-2%) from $248M in Q2 2026 to $242M in Q3 2026. The biggest changes: U.S. −$4.3M (-2%); International −$1.7M (-5%). Gross margin 95.6% against 95.3% (+0.3 pts).
Angi, Q3 2026: revenue $242M (-9% year over year), operating margin 6.4%, net earnings $1.3M, operating cash flow $28.5M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Gross margin | 95.6% | 95.3% | +0.3 pts |
| Operating margin | 6.4% | -94.3% | +100.6 pts |
| Net margin | 0.6% | -93.0% | +93.6 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| U.S. | $211M | $215M | −$4.3M | -2% |
| International | $30.9M | $32.6M | −$1.7M | -5% |
| Revenue | $242M | $248M | −$6.0M | -2% |
| Gross profit | $231M | $236M | −$5.0M | -2% |
| Cost of revenue | $10.7M | $11.7M | −$1.0M | -9% |
| Operating profit | $15.5M | −$234M | $249M | — |
| Operating expenses | $216M | $470M | −$254M | -54% |
| Pre-tax earnings | $13.1M | −$232M | $245M | — |
| Other expense, net | $2.4M | −$2.2M | $4.6M | — |
| Research & development | $9.3M | $10.9M | −$1.6M | -15% |
| Sales & marketing | $127M | $142M | −$15.2M | -11% |
| General & admin | $62.0M | $59.9M | $2.1M | +4% |
| Other operating costs | $17.6M | $257M | −$239M | -93% |
| Net earnings | $1.3M | −$231M | $232M | — |
| Income tax | $11.7M | −$918K | $12.7M | — |
| Depreciation | $16.9M | $21.0M | −$4.2M | -20% |
| Share-based compensation | $9.1M | $5.0M | $4.2M | +84% |
| Working capital & other | $1.2M | $232M | −$231M | -99% |
| Operating cash flow | $28.5M | $27.2M | $1.3M | +5% |
Questions
How much did Angi's revenue grow quarter over quarter in Q3 2026?
Angi's revenue fell $6.0M (-2%) from $248M in Q2 2026 to $242M in Q3 2026.
What drove Angi's revenue change in Q3 2026?
U.S.